老了胖点好！上海交大最新Cell子刊论文发现，脂肪产生的瘦素帮助对抗癌症

Core Viewpoint - The study reveals that the decline in leptin levels with age contributes to the accumulation of senescent CD8+ T cells in the tumor microenvironment, leading to weakened anti-tumor effects. Regulating leptin levels may be a promising therapeutic strategy for elderly cancer patients [3][7][10]. Group 1: Aging and T Cell Dysfunction - Aging is a major risk factor for various cancers, with patients aged 65 and above accounting for 60% of new cancer diagnoses [5]. - T cell immune remodeling due to aging results in poor clinical outcomes for cancer patients, as T cells lose physiological functions over time [5]. - Age-related changes in T cells and the impact of systemic metabolic alterations on T cell function and phenotype require further investigation [5]. Group 2: Role of Leptin - Leptin, produced by adipose tissue, informs the brain about the body's fat storage levels, with higher fat leading to increased leptin production [6]. - The study found that decreased leptin levels with age accelerate CD8+ T cell senescence, impairing T cell function in the tumor microenvironment [7][8]. - In human cancer patients, plasma leptin levels are negatively correlated with the degree of CD8+ T cell senescence within tumors [7][8]. Group 3: Implications for Treatment - The findings suggest that enhancing plasma leptin levels through the regulation of adipocyte metabolism may help prevent T cell senescence and improve anti-tumor immunity in elderly patients [10]. - Supplementing leptin could have therapeutic potential for elderly cancer patients [10].